Months ago, we asked an important question: will the economic destruction wrought by coronavirus affect upcoming marijuana legislation? We believed the answer was almost certainly “yes,” not for ethical reasons, but for financial reasons. Revenue during a deepening recession gets stuff done. Little did we know that there was a better question to ask! Can marijuana products be used to treat or prevent new coronavirus infections?
Scientists think the answer is yes.
University of Lethbridge researchers conducted an April study to show that high-concentration CBD could shut off the access routes used by coronavirus to infect a person, preventing the disease COVID-19 from ever taking hold.
Olga Kovalchuk said, “We were totally stunned at first, and then we were really happy.”
Her husband Igor added, “Our work could have a huge influence — there aren’t many drugs that have the potential of reducing infection by 70 to 80 percent.”
The biggest problem lies in the fact that cannabis can be used to treat all sorts of medical issues ranging from epilepsy to cancer — and governments still don’t legalize the drug for medical or commercial use without a brutal battle. Usually, marijuana legislation is only passed due to public referendum because lawmakers don’t agree with the public on the issue.
It was only a small study and more research is needed to verify the results. Olga said, “The key thing is not that any cannabis you would pick up at the store will do the trick.”
The study explained that certain powerful strains of cannabis could help them “develop easy-to-use preventative treatments in the form of mouthwash and throat gargle products” to reduce the ability of the infection to reach the airways.
It should be noted that the products used were high in CBD but low in THC, meaning they might save you from coronavirus — but they won’t get you high.